About Us
Anagnostics specializes in developing systems and tests for multiplex clinical and medical research diagnostics. Our aim is to provide solutions for unmet needs especially in the fields of drugs of abuse screening, severe infections and diagnostics in the field of oncology.
Anagnostics' vision is to establish our proprietary hybcell technology, a breakthrough development in multiplex diagnostics, as an internationally widely accepted standard.
Located in St. Valentin, Austria, we started our developments in 2006. Our team comprises of specialists in molecular diagnostics, mechatronics and software engineering. Our focus for development is user-friendliness of our products.
hybcell is the result of our goal to bring multiplexed diagnostics into routine analysis. hybcell is the worlds first cylindrical microarray, changing paradigms in microarray technology and re-defining biochips.
Our aim is to provide solutions for unmet needs especially in the fields of drugs of abuse screening, severe infections and diagnostics in the field of oncology. We are convinced that our products contribute to an advancement of modern medicine and thus in the well-being of patients.
